Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
about
Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of actionDynorphin, stress, and depressionAnabolic-androgenic steroid dependence: an emerging disorderPotential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodentsKappa-opioid ligands in the study and treatment of mood disordersPreclinical animal anxiety research - flaws and prejudices.Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on AddictionRole of kappa-opioid receptors in stress and anxiety-related behavior.Drug withdrawal conceptualized as a stressor.Dynorphin Controls the Gain of an Amygdalar Anxiety CircuitCRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behaviorAn Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical TrialsDirect targeting of peptidergic amygdalar neurons by noradrenergic afferents: linking stress-integrative circuitryAblation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticityDiscovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonistsRecent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.Affective cue-induced escalation of alcohol self-administration and increased 22-kHz ultrasonic vocalizations during alcohol withdrawal: role of kappa-opioid receptors.Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTic.Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.Analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic). Synthesis and in vitro and in vivo opioid receptor antagonist activityAmygdalar GABAergic-rich neural grafts attenuate anxiety-like behavior in rats.The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone.30 years of dynorphins--new insights on their functions in neuropsychiatric diseasesDistinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.The development and maintenance of drug addictionPeptide kappa opioid receptor ligands: potential for drug development.Virus-mediated shRNA knockdown of prodynorphin in the rat nucleus accumbens attenuates depression-like behavior and cocaine locomotor sensitization.Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and femalesEffects of the kappa opioid receptor antagonist, nor-binaltorphimine, on ethanol intake: impact of age and sexEffect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in ratsThe role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuseBehavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanismsSex differences in kappa opioid pharmacologyEffects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in miceEffects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.A role for the mu opioid receptor in the antidepressant effects of buprenorphine.Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats.
P2860
Q24642144-F43BD952-1AC6-4330-B962-35F3BF4E3CD4Q24650168-C3B88187-862A-40D2-83CA-3196851BAD72Q24653466-20D62E32-A413-4FD9-BA9D-239722FC6EB5Q24656590-74AF01A0-1B2A-4ED2-A400-38B3380A123AQ24657982-3FFB19F6-C5CE-4AED-BEE9-712570D9E779Q26749038-1EC4A0DC-3C90-4747-A681-6C5B924B2212Q26770785-BA83949C-7955-4E2B-A868-69EC97425ED7Q26991739-9B5EC760-3087-49EB-8726-922E5328392DQ26997989-64CCA497-0101-4B8C-AEDB-C092E5CD001DQ27319741-1F596DB2-E248-4588-AFE5-710B05CDD6FBQ28580222-1438F6B8-C359-4F0C-B11E-230534BF1BB9Q30375098-B9D1682B-7B56-420B-B278-A4CF515C51DEQ30394623-73D3794E-F887-4CE7-A974-A308A54BD4ECQ30435816-DF3E36F9-8D2F-40DA-95BA-B91DA850F454Q30436776-73DE001D-A94B-4365-A68A-53E224C85F5CQ30442231-D0521FBA-CC54-436D-A1A9-1D413548AEBDQ30442446-D32AFAC5-F05D-4467-B27B-D9D067F7E274Q30446679-0F560972-9A49-4A9D-8174-9B5784135F38Q30453815-377F7839-4F3B-48B4-8FA6-34FA99C8C114Q30474756-8983362F-DD57-4E52-A47C-9BB7C40AE507Q30478182-C483D106-4D56-4620-B96C-BED9585C59B3Q30479463-35DBACBA-27BA-4AC6-A9C3-4B454890F26EQ30481448-5323582F-6475-4BA6-9410-2521AAC9F4EFQ30481450-C9486495-4D50-4D7D-9656-2915E852E014Q30483034-2353AC41-EADE-4B8B-92CF-FAF6B4D5A0DEQ30560436-7825F5E6-10F5-41E6-A461-A70047EA3802Q33442900-965E6EC9-5288-457E-A53F-2542DAB1BC90Q33591477-9F54C9DE-99C6-4460-BCDF-85CB62E8841FQ33814395-97FF7D49-A8A5-4F9D-825C-1C044FD67384Q33818644-4E8575A8-C589-4522-A07F-C5005577B7CAQ33835737-C18A763C-211D-42D8-A2DD-7CC5A0E322B6Q33847097-C5667F54-DF86-43A2-803B-878ED2661C68Q33848200-15B49D5B-6BA7-4A69-B886-0F2015EBF5F1Q33890721-9CD930D4-3C4E-4A15-A551-0074DFD961C2Q33998470-139ACCE3-F57B-4673-BD2E-4CAA5CC2E522Q34144003-5449CED7-3B35-4462-992A-A2387322ECB0Q34436340-26EE9B19-DF8F-4A21-930B-B5597EA34A29Q34482680-818857C3-3138-4D08-B6EF-3C9DAF794652Q34544184-716BEFA4-967B-45BC-BFD6-49CDB7360BAAQ34632744-661AB510-5042-4332-A980-DACD201D5A8E
P2860
Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@ast
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@en
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@nl
type
label
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@ast
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@en
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@nl
prefLabel
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@ast
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@en
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@nl
P2093
P356
P1476
Anxiolytic-like effects of kap ...... rned and learned fear in rats.
@en
P2093
Allison T Knoll
Edward G Meloni
F Ivy Carroll
James B Thomas
William A Carlezon
P304
P356
10.1124/JPET.107.127415
P407
P577
2007-09-06T00:00:00Z